Disease Severity, Clinical Characteristics and Outcome of Patients Hospitalized with Novel Coronavirus Disease at a Tertiary Care Hospital, Rawalpindi

  • Muhammad Mahtab Shabir Pak-Emirates Military Hospital, (PEMH), Rawalpindi
  • Shazia Nisar Pak-Emirates Military Hospital, (PEMH), Rawalpindi
  • Zobia Urooj Pak-Emirates Military Hospital, (PEMH), Rawalpindi
  • Uzma Qayyum Pak-Emirates Military Hospital, (PEMH), Rawalpindi
  • Fozia Fatima Pak-Emirates Military Hospital, (PEMH), Rawalpindi
  • Zahid Hussain Pak-Emirates Military Hospital, (PEMH), Rawalpindi
Keywords: Covid-19, Hospitalized Patients, Novel Coronavirus Disease, SARS-CoV-2, Signs and Symptoms.

Abstract

Objective: To describe the clinical characteristics, signs & symptoms, disease severity, and outcome of patients
admitted with novel coronavirus infection.
Study Design: Comparative cross-sectional study.
Place and Duration of Study: The study was conducted in the Department of Medicine of Pak-Emirates Military
st th Hospital, (PEMH), Rawalpindi from May 1 , 2020 to June 30 , 2020.
Materials and Methods: Patients hospitalized with novel corona virus infection during the study period were
prospectively enrolled in this study. Patients at least 15 years and above, either gender, hospitalized with
confirmed diagnosis of covid-19 (SARS-CoV-2) were eligible to be enrolled. The study outcomes included
disease presentation, severity at time of reporting, admission to critical care or intensive care unit and
mortality. Patients were identified as mild, moderate, severe and critical in accordance with World Health
Organization guidelines, based on symptom severity, laboratory and imaging findings.
Results: There were 400 hospitalized patients with confirmed SARS-CoV-2, out of which 51 (12.8%) were
females, while 349 (87.3%) were males with overall mean age of 48.45±16.2 years. There were 300 (75.0%)
patients with mild disease severity, while 65 (16.3%), 20 (5.0%) and 15 (3.8%) with moderate, severe and critical
disease condition, respectively. The number of patients died were 22, with fatality rate of 5.5%. Age and
presence of comorbidities (cardiac disease, diabetes, hypertension, pulmonary disease, kidney disease) were
significantly associated with disease severity and death due to novel coronavirus infection.
Conclusion: Patients with older age, diabetes, hypertension, pulmonary disease, kidney disease were at higher
risk of developing severe disease condition and death due to novel coronavirus infection.

References

Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020; 12: 372-6.

Worldo'meter. Countries where COVID-19 has spread. [Updated on 27th October 2020, Accessed 27th October

. [Available at: https://www.worldometers.info /coronavirus/countries-where-coronavirus-has-spread/]

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020; 172:

-82.

World Health Organization. Estimating mortality from COVID-19. Scientific Brief. [Updated on 4th August 2020,

accessed on 26 October 2020]. [Available at: https://www.who.int/news-room/commentaries/

detail/estimating-mortality-from-covid-19]

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.

Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med.

; 8: 475-81.

Rajgor DD, Lee MH, Archuleta S. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis. 2020; 20: 776-7.

Wiersinga WJ, Rhodes A, Cheng AC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus

disease 2019 (COVID-19): a review. JAMA. 2020; 324: 782-93.

Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID Life 19): a clinical update. Front Med. 2020; 14: 126–35.

International Severe Acute Respiratory and emerging Infection Consortium (ISARIC). COVID-19 Clinical Research Re s o u rc e s . C a s e Re p o r t fo r m . [ Ava i l a b l e at : https://media.tghn.org/medialibrary/2020/03/ISARIC_COVID-19_CRF_V1.3_24Feb2020.pdf]

World Health Organization. Imterim Guidance: Clinical Management of severe acute respiratory when covid-19 disease is suspected. March 2020. Geneva. [Available at: https://apps.who.int/iris/bitstream/handle/10665/331446/WHO-2019-nCoV-clinical-2020.4-chi.pdf]

Force AD, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress

syndrome. JAMA. 2012; 307: 2526-33.

Centers for disease control and prevention (CDC). Overweight and Obesity. Defining adult overweight and

obesity. [Accessed online: 2 March 2021]. [Available online:https://www.cdc.gov/obesity/adult/defining.html]

Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020; 92: 577-83.

Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality of COVID- 19 patients in Wuhan, China. Clin. Microbiol Infect. 2020; 26: 767-72.

Wang R, Pan M, Zhang X, Han M, Fan X, Zhao F, et al. Epidemiological and clinical features of 125 Hospitalized

Patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. 2020; 95: 421-8.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368: m606

Sun Y, Koh V, Marimuthu K, Ng OT, Young B, Vasoo S, et al. Epidemiological and clinical predictors of COVID-19. Clin. Infect. Dis. 2020; 71:786-92.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. NEJM. 2020; 382: 1708-20.

Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive

symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020; 115: 766-73.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J

Autoimmun. 2020; 109: 102433.

Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, et al. Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan. Clin Infect Dis. 2020; 71: 740-7.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395; 1054-62.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91-5.

Emami A, Javanmardi F, Pirbonyeh N. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad. Emerg.2020; 8: e35-40.

Published
2021-09-28
Section
Original Article